Operator-reviewed computational design and analysis for proteins, antibodies, nanobodies, bispecifics, small molecules, and mRNA candidates. Workflows use available, licensed methods; retain method-specific evidence instead of blending incompatible scores; and deliver exact sequences or structures with provenance and an experimental decision plan. Research-use predictions do not establish expression, stability, affinity, immunogenicity, safety, or efficacy.